Arkolith/Insider Trading/CCCC/Form 4

Adams Kendra

Chief Financial OfficerC4 Therapeutics, Inc. (CCCC) · full profile →Form 4 · filed Sep 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2025Option exercise(M)6K—$0165K
Sep 18, 2025Tax withholding(F)3K$3.32$9K162K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-25-000223) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML